FW
Frederick Wayne A.I.
Director
BoardM
Insider track record
Board DirectorAcross 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Frederick Wayne A.I., Director. Insider active across 5 companies, notably INSULET CORP. Cumulatively, 23 filings have been recorded. Split: 0 buy · 5 sells. Total volume traded: €1m. Activity tracked since 27 May 2021. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations23 total
2,366 sharesClass A Common StockSEC:0001802241-26-000006:0
1,660 shares0Common StockSEC:0001145197-26-000123:0
1,997 shares0Class A Comnmon StockSEC:0001415889-25-014308:0
3,000 shares@ US$45.5464.1% of flowClass A Common StockSEC:0001415889-25-009766:0
1,825 shares@ US$275.00100.0% of flowCommon StockSEC:0001127602-25-010481:0
1,650 shares@ US$46.6935.9% of flowClass A Common StockSEC:0001415889-25-008653:0
500 shares@ US$251.0034.8% of flowClass A Common StockSEC:0001327811-25-000002:0
1,028 shares@ US$241.27965.2% of flowClass A Common StockSEC:0001327811-24-000218:0
1,555 shares0Class A Common StockSEC:0001327811-24-000119:0
38,514 shares0Class A Common StockSEC:0001415889-24-017307:0
1,380 shares0Common StockSEC:0001127602-24-016456:0
107 shares0Class A Common StockSEC:0001327811-23-000193:0
1,515 shares0Class A Common StockSEC:0001327811-23-000120:0
843 shares0Common StockSEC:0001127602-23-016711:0
7,250 sharesCommon StockSEC:0000899243-22-033657:0
5,248 shares0Class A Common StockSEC:0001327811-22-000144:0
2,077 shares0Class A Common StockSEC:0001327811-22-000126:0
4,500 shares0Common StockSEC:0000899243-22-021669:0
1,009 shares0Common StockSEC:0001127602-22-015762:0
2,750 shares0Common StockSEC:0000899243-21-025096
2,750 shares0Common StockSEC:0000899243-21-025096:0
808 shares0Common StockSEC:0001127602-21-018303:0
808 shares0Common StockSEC:0001127602-21-018303
About Frederick Wayne A.I.
Wayne A.I. Frederick serves as a Director at Insulet Corp and Forma Therapeutics Holdings, Inc. In this role, he participates in the governance of the companies and strategic decision-making. His experience in the medical sector allows him to provide valuable insights during board discussions.